An oral delivery vehicle based on konjac glucomannan acetate targeting the colon for inflammatory bowel disease therapy

Orally administered colon-targeted delivery vehicles are of major importance in the treatment of inflammatory bowel disease (IBD). However, it remains a challenge to maintain the integrity of such delivery vehicles during treatment, particularly in the gastric environment, which may cause untimely d...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chuang, Guo, Zhenzhao, Liang, Jialuo, Li, Na, Song, Rijian, Luo, Lei, Ai, Yilong, Li, Xia, Tang, Shunqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684466/
https://www.ncbi.nlm.nih.gov/pubmed/36440435
http://dx.doi.org/10.3389/fbioe.2022.1025155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684466/
https://www.ncbi.nlm.nih.gov/pubmed/36440435
http://dx.doi.org/10.3389/fbioe.2022.1025155

Ejemplares similares